Proximal Causal Inference for Modified Treatment Policies
修改处理政策的近端因果推断AI 解读 ↓
← 返回论文列表与筛选
阅读说明
本页整理公开书目信息，不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成，未完成全文核验，可能有误；具体假设、证明与结论请核对原文。摘要保留来源文本，未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要；缺少可靠材料时保留待补状态。
本页为预印本版本；arXiv 收录、作者填写的期刊信息以及作者既有发表经历，都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对，只展示已核实例，档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录，不合计多个记录；关联记录可能包含正式发表版本，不等于此版本单独引用。缺失不视为零，引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配，同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列，再参考通用方法与发表日期。
分类依据与纠错
AI 根据所提供的论文材料归类：摘要直接研究未测量混杂下修改连续处理剂量政策的因果识别与估计。
反馈分类问题
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
修改处理政策的近端因果推断
- 研究问题
- 连续暴露存在未测量混杂时，如何识别并估计把每个人实际剂量按预定规则修改后的平均反事实结果？
- 方法与思路
- 作者将近端因果框架扩展到修改处理政策，利用负控制处理和结果作为代理，并结合非参数干扰估计与去偏机器学习。
- 材料陈述的贡献
- 摘要称，该方法无需假设全部混杂因素已被测量，并通过疫苗免疫桥接研究和模拟展示实际应用及有限样本表现。
- 阅读关注点
- 应核对代理变量条件、政策修改规则、识别所需的桥函数要求，以及去偏估计依赖的收敛和支持条件。
- 阅读边界
- 这是 arXiv 预印本，同行评审或期刊接收未获核实；摘要未具体列出代理识别条件，不能认为任意代理均可消除混杂。
原文摘要
The proximal causal inference framework enables the identification and estimation of causal effects in the presence of unmeasured confounding by leveraging two disjoint sets of observed strong proxies: negative control treatments and negative control outcomes. In the point exposure setting, this framework has primarily been applied to estimands comparing counterfactual outcomes under a static fixed intervention or, possibly randomized, regime that depends on baseline covariates. For continuous exposures, alternative hypothetical scenarios can enrich our understanding of causal effects, such as those where each individual receives their observed treatment dose modified in a pre-specified manner - commonly referred to as modified treatment regimes. In this work, we extend the proximal causal inference framework to identify and estimate the mean outcome under a modified treatment regime, addressing this gap in the literature. We propose a flexible strategy that does not rely on the assumption that all confounders have been measured - unlike existing estimators - and leverages modern debiased machine learning techniques using non-parametric estimators of nuisance functions to avoid restrictive parametric assumptions. Our methodology was motivated by immunobridging studies of COVID-19 vaccines aimed at identifying correlates of protection, where the individual's underlying immune capacity is an important unmeasured confounder. We demonstrate its applicability using data from such a study and evaluate its finite-sample performance through simulation studies.